Summary & Overview
CPT 61510: Craniectomy/Craniotomy for Supratentorial Brain Tumor
Headline: Craniectomy for Supratentorial Brain Tumor (CPT 61510) Remains Core Neurosurgical Procedure
Lead: CPT 61510 denotes a craniectomy or craniotomy to excise a supratentorial brain tumor (excluding meningioma), a high-acuity neurosurgical intervention with significant clinical and billing implications across inpatient and ambulatory surgical settings.
What this code represents and why it matters: CPT 61510 captures definitive surgical management for many intracranial neoplasms located above the tentorium. As a primary operative code for tumor excision, it influences clinical workflow, resource allocation, and payment pathways for complex neurosurgical care nationally.
Key payers covered: This analysis addresses common national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Overview of what readers will learn: The publication provides a concise clinical and billing overview of CPT 61510, describes typical sites of service, and situates the code among related cranial procedure codes. Readers will find context on common clinical indications, the procedural setting, typical billing modifiers used with craniotomy procedures, and how CPT 61510 compares to adjacent CPT codes for other supratentorial cranial procedures. The piece highlights operational considerations relevant to coding, claims submission, and payer coverage discussions.
Limitations: Service-line metadata required for some benchmarking items is not provided. Data not available in the input.
CPT Code Overview
CPT 61510 describes a craniectomy or craniotomy for excision of a supratentorial brain tumor, except meningioma. This procedure is categorized under neurosurgery / craniotomy procedures and involves surgical opening of the skull to remove an intracranial tumor located in the supratentorial compartment. Typical sites of service for CPT 61510 are Hospital Inpatient (POS 21) and Ambulatory Surgery Center (POS 24).
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 58-year-old patient presents with progressive headaches, focal neurological deficits and imaging demonstrating a supratentorial mass suspicious for a primary brain neoplasm. The patient is admitted to the hospital (POS 21) for preoperative evaluation including MRI brain with contrast, neurosurgical consultation, anesthesia assessment, and medical optimization. On the planned operative day the patient is taken to the operating room or ambulatory surgery center (POS 24) for a craniectomy/craniotomy to excise the supratentorial brain tumor. Intraoperative neuronavigation and microsurgical techniques are used, and postoperative monitoring occurs in a neurosurgical ward or intensive care unit as indicated. Pathology is obtained intraoperatively and submitted for final diagnosis; postoperative imaging confirms the extent of resection and guides subsequent oncologic or neurologic management.
Coding Specifications
-
Modifiers
-
62- Two Surgeons: Used when two surgeons from different surgical specialties or when the complexity requires two primary surgeons who each perform distinct components of the procedure. -
80- Assistant Surgeon: Used when an assistant surgeon provides surgical assistance to the primary surgeon; typically billed by the assistant surgeon and appended to the primary procedure code when payer policy allows. -
Provider Taxonomies
| Taxonomy Code | Specialty |
|---|---|
207T00000X | Neurological Surgery |
208600000X | Surgery |
207ZP0102X | Pediatric Neurosurgery |
Related Diagnoses
-
C71.9— Malignant neoplasm of brain, unspecifiedThis diagnosis represents a primary malignant brain tumor that may necessitate supratentorial tumor excision under
61510when tumor location and pathology indicate resection. -
D33.0— Benign neoplasm of brain, supratentorialBenign supratentorial tumors (for example low-grade gliomas) can be indications for craniectomy/craniotomy for excision using
61510when the lesion is not a meningioma. -
D43.0— Neoplasm of uncertain behavior of brain, supratentorialLesions of uncertain histologic behavior identified on imaging may prompt surgical excision for diagnosis and treatment using
61510. -
G93.5— Compression of brainMass effect or brain compression from a supratentorial lesion may require decompression and tumor excision performed under
61510. -
R47.01— AphasiaFocal neurologic deficits such as aphasia can be a presenting symptom localizing a supratentorial lesion and support medical necessity for operative management with
61510.
Related CPT Codes
| CPT Code | Description | Relationship to 61510 |
|---|---|---|
61512 | Craniectomy, trephination, bone flap craniotomy; not excising meningioma, supratentorial (abbreviated) | Alternative or adjacent code when the procedure specifically excludes meningioma excision; may be selected when operative findings or pathology differ from preoperative impression. |
61514 | Craniectomy, trephination, bone flap craniotomy; not excising brain abscess, supratentorial (abbreviated) | Alternative when the operative procedure addresses non-neoplastic pathology such as an abscess rather than tumor excision. |
61516 | Craniectomy, trephination, bone flap craniotomy; not excising/fenestrating cyst, supratentorial (abbreviated) | Alternative when the target lesion is a cyst requiring fenestration or drainage rather than tumor resection. |
-
Common clinical workflow notes:
-
61512,61514, and61516are used as alternatives depending on intraoperative diagnosis and documented intent; they may be chosen instead of61510when the lesion type is not a supratentorial brain tumor excision. -
Codes may be selected based on final operative and pathology documentation to reflect the actual procedure performed.
National Reimbursement Benchmarks
National Medicare mean allowed rate is $2,163.81 compared with the BUCA (average commercial) mean of $2,837.73 for 61510, indicating commercial averages exceed Medicare by $673.92 on a national basis. The largest commercial payers—UnitedHealth Group and Cigna—have significantly higher mean rates than Medicare and BUCA.
Dispersion measured as the interquartile range (P75 − P25) varies across payers. UnitedHealth Group shows one of the widest spreads (4,793.00 − 2,505.00 = $2,288.00), followed by Cigna (4,388.33 − 2,326.50 = $2,061.83). Medicare is the tightest (2,262.00 − 2,063.00 = $199.00), with Aetna also relatively tight (2,467.00 − 1,244.00 = $1,223.00). The table and chart below present the full payer breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.